|
English
|
正體中文
|
简体中文
|
总笔数 :0
|
|
造访人次 :
52698569
在线人数 :
1250
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"choi hi"的相关文件
显示项目 1-4 / 4 (共1页)
1
每页显示[10|25|50]项目
| 國家衛生研究院 |
2020-08-11 |
PT320, sustained-release exendin-4, mitigates L-DOPA-Induced dyskinesia in a rat 6-Hydroxydopamine model of Parkinson’s disease
|
Yu, SJ;Chen, S;Yang, YY;Glotfelty, EJ;Jung, J;Kim, HK;Choi, HI;Choi, DS;Hoffer, BJ;Greig, NH;Wang, Y |
| 國家衛生研究院 |
2018-07-16 |
Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease
|
Chen, S;Yu, SJ;Li, Y;Lecca, D;Glotfelty, E;Kim, HK;Choi, HI;Hoffer, BJ;Greig, NH;Kim, DS;Wang, Y |
| 國家衛生研究院 |
2018-07-16 |
Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease [Erratum: Scientific Reports. 2018 Jul 16;8:Article number 10722.]
|
Chen, S;Yu, SJ;Li, Y;Lecca, D;Glotfelty, E;Kim, HK;Choi, HI;Hoffer, BJ;Greig, NH;Kim, DS;Wang, Y |
| 國家衛生研究院 |
2017-09 |
A new treatment strategy for Parkinson's disease through the gut-brain axis: The glucagon-like peptide-1 receptor pathway
|
Kim, DS;Choi, HI;Wang, Y;Luo, Y;Hoffer, BJ;Greig, NH |
显示项目 1-4 / 4 (共1页)
1
每页显示[10|25|50]项目
|
